Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

Groundbreaking research has transformed our understanding of acupuncture's role in treating sciatica, a debilitating ...

Insect venom may seem like an unlikely ally in the discovery of new human pain treatments, but the latest findings into the ...

Around eight out of 10 children survive their cancer for 10 years or more, figures suggest, but more than half of them report delayed and ongoing pain in adulthood ...

Jill Becher spent more than three years in agonizing pain. After one surgery failed, a riskier treatment provided relief.

Expanding Ketamir-2's Potential Beyond Neuropathic Pain: MIRA is actively preparing to launch preclinical trials for ...

秋风送爽，丹桂飘香。近日（9月19日-22日），由中华医学会、中华医学会神经病学分会主办，河南省医学会承办的“中华医学会第二十七次神经病学学术会议”在美丽的郑州顺利召开。国内外知名专家学者齐聚，共享学术饕餮盛宴。神经病理性疼痛（NP）指由躯体感觉系统 ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

Recent evidence suggests that acupuncture can help relieve the pain caused by sciatica, a common condition in which the ...

New research presented at the American Academy of Ophthalmology’s Cornea Subspecialty Day is part of the part of the 8-year ...

In 2020, an estimated 54 million adults in the U.S. were living with chronic pain. Over 25 percent of them were treating ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to ...